Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market, 2016 2022 (USD Million)

2.2. Global enzyme-linked immunosorbent assay (ELISA) testing market : Snapshot

Chapter 3. Enzyme-linked immunosorbent assay (ELISA) testing Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market drivers: Impact analysis

3.2.2. Emergence of cost effective technologies and laboratory automation for ELISA assay

3.2.3. Increasing research and development on biomarkers and monoclonal antibodies (mABs)

3.3. Market restraints


3.3.1. Global enzyme-linked immunosorbent assay (ELISA) testing market restraints: Impact analysis

3.3.2. Threat of substitution by new technologies

3.4. Opportunities


3.4.1. Increasing need for accurate and early disease diagnosis

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by test type segment

3.6.2. Market attractiveness analysis, by application segment

3.6.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: company market share, 2016

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Therapy Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Therapy and Regional Expansion

4.3. Price Trend Analysis

4.4. Technology Portfolio

Chapter 5. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Test Type Segment Analysis


5.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Test Type overview


5.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by Test Type, 2016 and 2022

5.2. Sandwich ELISA


5.2.1. Global Sandwich ELISA market , 2016 2022(USD Million)

5.3. Indirect ELISA


5.3.1. Global Indirect ELISA market , 2016 2022(USD Million)

5.4. Multiple and portable ELISA


5.4.1. Global Multiple and portable ELISA market , 2016 2022(USD Million)

5.5. Competitive ELISA


5.5.1. Global Competitive ELISA market , 2016 2022(USD Million)

Chapter 6. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Application Segment Analysis


6.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Application overview


6.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by Application, 2016 and 2022

6.2. Immunology


6.2.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Immunology, 2016 2022 (USD Million)

6.3. Inflammation


6.3.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Inflammation, 2016 2022(USD Million)

6.4. Infectious diseases


6.4.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Infectious diseases, 2016 2022 (USD Million)

6.5. Cancer


6.5.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Cancer, 2015 - 2021(USD Million)

6.6. Protein quantification


6.6.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for Protein quantification, 2015 - 2021(USD Million)

6.7. Others


6.7.1. Global enzyme-linked immunosorbent assay (ELISA) testing market for other applications , 2016 2022 (USD Million)

Chapter 7. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Regional Segment Analysis


7.1. Global enzyme-linked immunosorbent assay (ELISA) testing market: Regional overview


7.1.1. Global enzyme-linked immunosorbent assay (ELISA) testing market revenue share, by region, 2016 and 2022

7.2. North America


7.2.1. North America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022 (USD Million)

7.2.2. North America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)

7.2.3. U.S.


7.2.3.1. U.S. enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.2.3.2. U.S. enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.3. Europe


7.3.1. Europe enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.3.2. Europe enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.3.3. Germany


7.3.3.1. Germany enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.3.3.2. Germany enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.3.4. France


7.3.4.1. France enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.3.4.2. France enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.3.5. UK


7.3.5.1. UK enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.3.5.2. UK enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.4. Asia Pacific


7.4.1. Asia Pacific enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022, (USD Million)

7.4.2. Asia Pacific enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022, (USD Million)

7.4.3. China


7.4.3.1. China enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.4.3.2. China enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.4.4. Japan


7.4.4.1. Japan enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.4.4.2. Japan enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.4.5. India


7.4.5.1. India enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.4.5.2. India enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.5. Latin America


7.5.1. Latin America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.5.2. Latin America enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022(USD Million)

7.5.3. Brazil


7.5.3.1. Brazil enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022(USD Million)

7.5.3.2. Brazil enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)

7.6. Middle East and Africa


7.6.1. Middle East and Africa enzyme-linked immunosorbent assay (ELISA) testing market revenue, by test type, 2014 2022 (USD Million)

7.6.2. Middle East and Africa enzyme-linked immunosorbent assay (ELISA) testing market revenue, by application, 2014 2022 (USD Million)

Chapter 8. Company Profile


8.1. Thermo Fisher Scientific. Inc.


8.1.1. Overview

8.1.2. Financials

8.1.3. Therapy portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. American Laboratory Products Company (ALPCO)


8.2.1. Overview

8.2.2. Financials

8.2.3. Therapy portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. BD Biosciences


8.3.1. Overview

8.3.2. Financials

8.3.3. Therapy portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. Bio-Rad Laboratories, Inc.


8.4.1. Overview

8.4.2. Financials

8.4.3. Therapy portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. BioMrieux


8.5.1. Overview

8.5.2. Financials

8.5.3. Therapy portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Ortho-Clinical Diagnostics, Inc.


8.6.1. Overview

8.6.2. Financials

8.6.3. Therapy portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. R D Systems Inc.


8.7.1. Overview

8.7.2. Financials

8.7.3. Therapy portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. ZEUS Scientific, Inc.


8.8.1. Overview

8.8.2. Financials

8.8.3. Therapy portfolio

8.8.4. Business strategy

8.8.5. Recent developments